Corvus Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

17.82 +0.61 (+3.54%) USD | NASDAQ | Feb 24, 16:00

17.87 +0.05 (+0.28%) After-Hours: 04:41

View Other Long Term Liabilities (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Plus Therapeutics, Inc.	--
Geron Corp.	Upgrade
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	Upgrade